• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.59%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    112.59 Down 8.67(7.15%) 10:43AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:121.26
    Open:112.40
    Bid:112.98 x 500
    Ask:113.02 x 200
    1y Target Est:133.00
    Beta:-0.95
    Next Earnings Date:N/A
    Day's Range:111.55 - 115.94
    52wk Range:59.79 - 127.69
    Volume:1,751,626
    Avg Vol (3m):1,514,770
    Market Cap:27.08B
    P/E (ttm):N/A
    EPS (ttm):-2.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    VRTXDown 7.15%27.08B
    BMYDown 1.48%100.22B
    MRKDown 0.28%174.70B
    PTCTUp 1.66%1.61B

    Key Statistics

    Forward P/E (1 yr):24.94
    P/S (ttm):37.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.76
    Quarterly EPS Est (Mar-15) :-0.69
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-8.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback